BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35818241)

  • 21. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
    Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
    Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer.
    Spencer C; Petrovic I; Fatemi S
    J Clin Endocrinol Metab; 2011 May; 96(5):1283-91. PubMed ID: 21325460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?
    Mariotti S; Barbesino G; Caturegli P; Marinó M; Manetti L; Pacini F; Centoni R; Pinchera A
    J Clin Endocrinol Metab; 1995 Feb; 80(2):468-72. PubMed ID: 7852506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroglobulin antibody (TgAb) methods - Strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer.
    Spencer C; Fatemi S
    Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):701-12. PubMed ID: 24094640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and implications of negative serum thyroglobulin but positive I-131 whole-body scans in patients with well-differentiated thyroid cancer prepared with rhTSH or thyroid hormone withdrawal.
    Cherk MH; Francis P; Topliss DJ; Bailey M; Kalff V
    Clin Endocrinol (Oxf); 2012 May; 76(5):734-40. PubMed ID: 22050475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Detection of Serum IgMs to Thyroglobulin in Subacute Thyroiditis Suggests a Protective Role of IgMs in Thyroid Autoimmunity.
    Ricci D; Brancatella A; Marinò M; Rotondi M; Chiovato L; Vitti P; Latrofa F
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 31996918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum thyroglobulin (Tg) and thyroglobulin antibodies (TgAb) in thyroid cancer.
    Sundram FX; Sethi VK; Aw SE
    Ann Acad Med Singap; 1986 Oct; 15(4):535-8. PubMed ID: 3566173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analytical and clinical performance of thyroglobulin autoantibody assays in thyroid cancer follow-up.
    Katrangi W; Grebe SKG; Algeciras-Schimnich A
    Clin Chem Lab Med; 2017 Oct; 55(12):1987-1994. PubMed ID: 28672730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring differentiated thyroid cancer patients with negative serum thyroglobulin. Diagnostic implication of TSH-stimulated antithyroglobulin antibody.
    Nam HY; Paeng JC; Chung JK; Kang KW; Cheon GJ; Kim Y; Park DJ; Park YJ; Min HS; Lee DS
    Nuklearmedizin; 2014; 53(2):32-8. PubMed ID: 24276613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Application Value of High-Frequency Ultrasound Combined with Detection of Serum High Mobility Group Box 1, Soluble IL-2 Receptor, and Thyroglobulin Antibody in Diagnosing Thyroid Cancer.
    Li N; Zhang J; Meng X; Yao W
    J Healthc Eng; 2022; 2022():7851436. PubMed ID: 35392142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Value of Serum Thyroglobulin and Anti-Thyroglobulin Antibody in Thyroid Carcinoma Patients following Thyroidectomy.
    Zahra HO; Omran GA; Gewely AG; Eldehn AF; Abdo W; Elmahallawy EK; Okda TM
    Diagnostics (Basel); 2021 Nov; 11(11):. PubMed ID: 34829426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance Evaluation of the Serum Thyroglobulin Assays With Immunochemiluminometric Assay and Immunoradiometric Assay for Differentiated Thyroid Cancer.
    Cho YY; Chun S; Lee SY; Chung JH; Park HD; Kim SW
    Ann Lab Med; 2016 Sep; 36(5):413-9. PubMed ID: 27374705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Applicability of Low Levels of Thyroglobulin Autoantibodies as Cutoff Point for Thyroglobulin Autoantibody Positivity.
    Dekker BL; van der Horst-Schrivers ANA; Sluiter WJ; Brouwers AH; Lentjes EGWM; Heijboer AC; Muller Kobold AC; Links TP
    Thyroid; 2019 Jan; 29(1):71-78. PubMed ID: 30351209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of Tg and TgAb for metastasis following ablation in patients with differentiated thyroid carcinoma coexistent with Hashimoto thyroiditis.
    Chai H; Zhu ZJ; Chen ZQ; Yu YL
    Endocr Res; 2016 Aug; 41(3):218-22. PubMed ID: 27158852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of endogenous TgAb upon serum Tg measurement results and Tg positive rate in patients with differentiated thyroid carcinoma].
    Zhang W; Deng H; Pan M; Huang R; Tang G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Aug; 30(4):803-7. PubMed ID: 24059060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of thyroglobulin antibody epitopes in differentiated thyroid cancer.
    Lupoli GA; Okosieme OE; Evans C; Clark PM; Pickett AJ; Premawardhana LD; Lupoli G; Lazarus JH
    J Clin Endocrinol Metab; 2015 Jan; 100(1):100-8. PubMed ID: 25322272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical laboratory verification of thyroglobulin concentrations in the presence of autoantibodies to thyroglobulin: comparison of EIA, radioimmunoassay and LC MS/MS measurements in an Urban Hospital.
    Wheeler SE; Liu L; Blair HC; Sivak R; Longo N; Tischler J; Mulvey K; Palmer OMP
    BMC Res Notes; 2017 Dec; 10(1):725. PubMed ID: 29221487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas.
    Spencer CA; Bergoglio LM; Kazarosyan M; Fatemi S; LoPresti JS
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5566-75. PubMed ID: 15985472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma.
    Kim WG; Yoon JH; Kim WB; Kim TY; Kim EY; Kim JM; Ryu JS; Gong G; Hong SJ; Shong YK
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4683-9. PubMed ID: 18812478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroglobulin (Tg) recovery testing with quantitative Tg antibody measurement for determining interference in serum Tg assays in differentiated thyroid carcinoma.
    Persoon AC; Links TP; Wilde J; Sluiter WJ; Wolffenbuttel BH; van den Ouweland JM
    Clin Chem; 2006 Jun; 52(6):1196-9. PubMed ID: 16574765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.